This hypothesis is consistent with recent studies that show Septin 9 isoform over-expression is associated with an oncogenic phenotype [24], [25] and evidence that Septin 9 v1 over-expression is associated with tumor resistance to drugs that disrupt microtubule formation [34]. Here, SEPTIN9 is linked to neoplasm.